These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12397872)

  • 21. Blepharospasm as an obsessive-compulsive phenomenon.
    Jain M; Aggarwal A; Khandelwal A
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E19-20. PubMed ID: 21677211
    [No Abstract]   [Full Text] [Related]  

  • 22. Obsessive compulsive disorder and depression--first results of a prospective study on 74 patients.
    Demal U; Zitterl W; Lenz G; Zapotoczky HG; Zitterl-Eglseer K
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):801-13. PubMed ID: 8870065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
    Howland RH
    Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
    [No Abstract]   [Full Text] [Related]  

  • 24. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the quality of care for depressed patients with comorbid psychiatric disorders: a review.
    Dunner DL
    Clin Perform Qual Health Care; 1997; 5(1):11-5. PubMed ID: 10164994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant medications in children.
    Vitiello B; Swedo S
    N Engl J Med; 2004 Apr; 350(15):1489-91. PubMed ID: 15071123
    [No Abstract]   [Full Text] [Related]  

  • 27. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does SSRI augmentation with antidepressants that influence noradrenergic function resolve depression in obsessive-compulsive disorder?
    Mancini C; Van Ameringen M; Farvolden P
    J Affect Disord; 2002 Feb; 68(1):59-65. PubMed ID: 11869783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sertraline and tic: case report.
    Ghanizadeh A
    Pharmacopsychiatry; 2007 Nov; 40(6):289-90. PubMed ID: 18030654
    [No Abstract]   [Full Text] [Related]  

  • 31. Compulsive personality as predictor of response to serotonergic antidepressants.
    Pollitt J; Tyrer P
    Br J Psychiatry; 1992 Dec; 161():836-8. PubMed ID: 1483171
    [No Abstract]   [Full Text] [Related]  

  • 32. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoxetine in anorexia nervosa.
    Lee S
    J Clin Psychiatry; 1991 May; 52(5):240-1. PubMed ID: 2033033
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA; Bullock T; Montgomery DB; Montgomery SA
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract]   [Full Text] [Related]  

  • 38. Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.
    Sutor B; Hansen MR; Black JL
    Downs Syndr Res Pract; 2006 Jul; 10(1):1-3. PubMed ID: 16869367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should young people be given antidepressants? No.
    Timimi S
    BMJ; 2007 Oct; 335(7623):751. PubMed ID: 17932206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.